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Chemical composition and bioactive properties of
the wild mushroom Polyporus squamosus (Huds.)
Fr: a study with samples from Romania
Andrei Mocan,a,b Ângela Fernandes,a Lillian Barros, a Gianina Crişan,b
Marija Smiljković,c Marina Soković c and Isabel C. F. R. Ferreira *a
In Eastern Europe, wild mushrooms are widely collected in mountain areas and used for their medicinal
properties or as healthy foods. This study aimed at determining the chemical composition (nutritional
value, free sugars, organic acids, phenolic compounds, fatty acids and tocopherols) and bioactive pro-
perties (antioxidant, antimicrobial and antiquorum sensing) of wild Polyporus squamosus (Huds.) Fr from
Romania. The results indicate that the fruiting bodies of P. squamosus are rich in carbohydrates (74.22 g
per 100 g dw) and proteins (18.7 g per 100 g dw). Trehalose was the main free sugar, while malic acid was
the organic acid detected in the highest amount (2.21 g per 100 g dw), and p-hydroxybenzoic acid was
the main phenolic compound. Among tocopherols, β-tocopherol was the most abundant form (114.7 µg
per 100 g dw). Additionally, regarding the fatty acids’ pattern, polyunsaturated acids represent more than
57% of all fatty acids, followed by monounsaturated fatty acids (24.96%). The highest measured antioxidant
effect of P. squamosus extract was found using the TBARS inhibition assay (EC50 = 0.22 mg mL
−1), fol-
lowed by the β-carotene/linoleate assay (EC50 = 1.41 mg mL−1). A minimal inhibitory concentration of the
tested extracts was obtained between 0.61–20.4 mg mL−1, while the bactericidal effect was achieved
between 1.2–40.8 mg mL−1. Antibiofilm potential was obtained at all tested concentrations, and sub-
inhibitory concentrations of the extract exhibited an antiquorum effect and reduced the formation of
P. aeruginosa pili, which all together influenced the virulence of this bacterium. Due to the investigated
bioactivities and compounds of P. squamosus and its well-balanced nutritional profile, this mushroom
can be further used as a medicinal ingredient based on its antioxidative and antimicrobial potential.
1. Introduction
Over the last decade dietary habits have progressively changed,
at a global scale, with nutraceuticals, functional foods and
food supplements receiving an increasing demand from con-
sumers, and consequently gaining scientific interest from
academia.1 Nowadays considering the extensive evidence of
health-promoting abilities of different food classes, great
attention is given by the consumers and food industry to
natural foods, especially to wild foods coming from unpolluted
areas (i.e. mountains).2,3 Wild edibles include annual and
perennial herbs, forbs, vines, sedges and rushes, grasses,
broadleaved and needle-like or scale-like leaved shrubs, trees,
ferns, as well as mushrooms, algae and lichens.2,4
Mushrooms possess an important nutritional value since
they are quite rich in proteins, having a high content of essen-
tial amino acids and fibers, and being poor in fat. Moreover,
edible mushrooms represent important sources of vitamins
(B1, B2, B12, C, D, and E).5–8 Additionally, they represent an
important source of different bioactive compounds such as
unsaturated fatty acids, phenolic compounds, terpenoids, and
carotenoids, and can be ultimately developed into functional
foods, nutraceuticals or pharmaceutical products, taking
advantage of their unique chemical features and the advantage
of the additive and synergistic effects of all their panel of bio-
active compounds.5,8–13
The usage of wild edible mushrooms in cooking, traditional
medicine, and religious rituals is a very well established and
appreciated practice which has been maintained and
developed in different cultures and civilizations around the
world, particularly in South and Central-Eastern Europe,
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China, Mexico and Latin America.14–17 Moreover, the con-
sumption of wild growing mushrooms is currently preferred to
eating of cultivated fungi in many countries of Central and
Eastern Europe.18 Collecting them is very popular in numerous
regions in the mountain areas, representing an important
component of the human diet, and the main proportion
amongst other wild foods.19 However, despite a lack of accu-
rate data about the use of wild mushrooms, it is estimated that
their consumption may reach several kilograms per person per
year.
The several changes in the environmental factors have an
important impact on human health currently, which is
reflected in the production of free radical species which are
linked to the damage of vital biomolecules or cell structures
(DNA, proteins and membranes).20 Furthermore, this physio-
logical condition is associated with the development of serious
ailments such as cardiovascular and neurodegenerative dis-
eases, and different forms of cancers. Besides their nutritional
value, compounds from mushrooms can act as antioxidant,
antitumor, antiviral, antimicrobial, and immunomodulatory
agents.11,21–27 Moreover, they have been shown to be modu-
lators of the immune system and to exert hypoglycemic, anti-
thrombotic, antibiotic, antiviral, antihypertensive, and anti-
lipidemic properties, as well as anti-inflammatory and anti-
microbial actions.28–30
Several vitamins and minerals such as ascorbic acid, niacin,
riboflavin, thiamine and some essential micronutrients were
described in species of the genus Polyporus. Polyporus squamo-
sus (Huds.) Fr is an edible mushroom at an early and tender
stage, used frequently as a spice, and being widely distributed
in Europe, Asia, North America and Australia.24 Polyporus
species are well used medicinal mushrooms being described
to possess diuretic, cytotoxic, nephroprotective, hepatoprotec-
tive, immuno-enhancing, anti-inflammatory, antioxidative,
hair-growing, and antimicrobial activities.31–35 Particularly,
P. squamosus was shown to possess antioxidant,36–38 immuno-
modulating,39 antibacterial,37 antifungal24 properties as well
as antibiofilm and anti-quorum sensing activities.24 Moreover,
there are some studies reporting the chemical composition of
P. squamosus fruiting bodies from Portugal, Serbia, and
Turkey.24,36,40,41
Different mushrooms are investigated by the scientific com-
munity, in searching for new therapeutic alternatives, and
many results proved their bioactive properties as well as their
medicinal value.11,13,21,25,28,29,34,39,42,43 The mountainous area
of Romania, due to climatic conditions and flora diversity, is
one of the European regions with high wild edible mushroom
diversity, many of them being medicinal as well. Despite of
their great popularity, data regarding the chemical compo-
sition and bioactive properties of the wild mushrooms avail-
able in the region as well as their nutritional value are very
meager. Therefore, the aim of the present study was to provide
a comprehensive study on the chemical composition of
P. squamosus collected from Romania as well as on some of its
biological activities (antioxidant, antimicrobial, and anti-
quorum sensing).
2. Materials and methods
2.1. Standards and reagents
The following chemicals were of HPLC grade and obtained
from Lab-Scan (Lisbon, Portugal): acetonitrile 99.9%, n-hexane
95% and ethyl acetate 99.8%. All other chemicals including
methanol were of analytical grade and obtained from common
providers. Fatty acid methyl ester (FAME) reference standard
mixture 37 (standard 47885-U) was purchased from Sigma
(St Louis, MO, USA), as well as sugar standards, organic acids,
phenolic acids, and Trolox (6-hydroxy-2,5,7,8-tetramethyl-
chroman-2-carboxylic acid). Tocol and tocopherol standards
were purchased from Matreya (Pleasant Gap, PA, USA). 2,2-
Diphenyl-1-picrylhydrazyl (DPPH) was obtained from Alfa
Aesar (Ward Hill, MA, USA). Water was treated in a Milli-Q
water purification system (TGI Pure Water Systems, USA).
Mueller–Hinton agar (MH) and malt agar (MA) were obtained
from the Institute of Immunology and Virology, Torlak
(Belgrade, Serbia).
2.2. Mushroom samples
Fruiting bodies (tender stage) of P. squamosus were collected
from the Apuseni mountain region, Sartăş, Alba County,
Transylvania, Romania in May 2017, and authenticated by
Dr Andrei Mocan, Senior Lecturer at the Department of
Pharmaceutical Botany, “Iuliu Haţieganu” University of
Medicine and Pharmacy, Cluj-Napoca, Romania, and a
voucher specimen was deposited at the herbarium of the
Department of Pharmaceutical Botany, “Iuliu Haţieganu”
University of Medicine and Pharmacy. Fresh and cleaned fruit-
ing bodies were randomly divided and dried using a laboratory
plant dryer at 25 °C until reaching a constant mass.
Afterwards, the mushroom material was ground into a fine
powder using a laboratory mill, mixed to obtain a homo-
geneous sample, and kept at 4 °C, for further analyses. All
assays were carried out three times (three separate samplings)
and in triplicate, and the values reported are represented as
average and standard deviation (SD).
2.3. Extraction procedure
The ground powder mushroom material (1.5 g) was stirred
with methanol (30 mL) at 25 °C at 150 rpm for 1 h, and further
filtered through Whatman no. 4 paper. Additionally, the
residue was further extracted with an additional portion of
methanol. After combining the two fractions, the methanolic
extracts were evaporated using a rotary evaporator (Büchi
R-210; Flawil, Switzerland) under reduced pressure, re-
dissolved in methanol at a concentration of 40 mg mL−1
(stock solution), and stored at 4 °C for further analyses
(HPLC-DAD-ESI/MS and antioxidant assays).42 For the evalu-
ation of antimicrobial activity, the dry extract was dissolved in
5% DMSO (1 mg mL−1), following the procedure mentioned in
section 2.6.
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2.4.1. Nutritional and energetic value. The nutritional
value of the mushroom sample was analyzed using AOAC pro-
cedures concerning the composition in proteins, fat, carbo-
hydrates and ash.44 For the estimation of the crude protein
content (N × 4.38) the macro-Kjeldahl method was used; the
crude fat content was determined by extracting a known
weight of sample with petroleum ether using a Soxhlet appar-
atus while the ash content was determined by calcination at
600 ± 15 °C. The total carbohydrate content was calculated
by difference and total energy was calculated according to the
following equation: Energy (kcal) = 4 × (g protein + g carbo-
hydrates) + 9 × (g fat).
2.4.2. Determination of free sugars. Free individual sugars
were assessed from the fruiting body by high performance
liquid chromatography coupled to a refraction index detector
(HPLC-RI, Knauer, Smartline system 1000; Berlin, Germany).
The extraction procedure and HPLC analysis were assessed
using the procedures previously described.45,46 The identifi-
cation of the sugars was performed by comparing the relative
retention times of sample peaks with standards under the
same chromatographic conditions and the obtained data were
analyzed using Clarity 2.4 Software (DataApex, Podohradska,
Czech Republic). The internal standard (IS, melezitose)
method was used, and the quantification was based on the RI
signal response of each standard. The results were expressed
in g per 100 g of dry weight (dw).
2.4.3. Determination of phenolic compounds. The above-
mentioned extract was diluted to a concentration of 10
mg mL−1 and filtered through a 0.22 µm nylon filter before
chromatographic analysis. The individual phenolic acids were
determined by using a Dionex Ultimate 3000 UPLC system
(Thermo Scientific, San Jose, CA, USA) as previously
described.42,47 DAD detection was carried out using 280 nm as
a preferred wavelength, while further structural analysis was
assessed using a mass spectrometer (MS). The MS detection
was performed in the negative mode, using a Linear Ion Trap
LTQ XL mass spectrometer (ThermoFinnigan, San Jose, CA,
USA) equipped with an electrospray ionization (ESI) source.
The phenolic acids were characterized according to their UV
and MS spectra and retention times, in comparison with
authentic standards when available. For quantitative analysis,
calibration curves were prepared from different standard com-
pounds. The quantitative results were expressed as mg per
100 g of dry weight fruiting body (dw).
2.4.4. Determination of organic acids. The individual
organic acids were determined following a procedure pre-
viously described.48 Briefly, the analysis was performed using
a Shimadzu 20A Series UFLC (Shimadzu Corporation, Kyoto,
Japan). The detection was carried out using a diode array
detector (DAD), at 215 nm and 245 nm as preferred wave-
lengths. The organic acids found were quantified using
calibration curves obtained for each commercial compound.
The results were expressed in g per 100 g of dried weight (dw)
fruiting body.
2.4.5. Determination of fatty acids. The fatty acid compo-
sition was evaluated after a transesterification procedure as
previously described.45,46 The profile of the fatty acids was ana-
lyzed with a DANI 1000 gas chromatograph (GC) with a flame
ionization detector (FID). The identification of the fatty acids
was assessed by comparing the relative retention times of
FAME peaks from samples with standards. Finally, the results
were recorded and processed using Clarity 4.0.1.7 Software
(DataApex, Podohradska, Czech Republic). The results were
expressed in relative percentage of each fatty acid.
2.4.6. Determination of tocopherols. The tocopherol
content was assessed as previously described,6 using an HPLC
system (Knauer, Smartline system 1000; Berlin, Germany)
coupled with a fluorescence detector (FP-2020; Jasco,
Oklahoma City, OK, USA). Individual compounds were identi-
fied by comparison with authentic standards under the same
chromatographic conditions. By using the internal standard
method (tocol, IS), the quantification was based on the fluo-
rescence signal response, and the tocopherol content was
expressed in µg per 100 g of dried weight (dw).
2.5. Evaluation of antioxidant activity
2.5.1. General. The antioxidant activity was evaluated
through several assays based on different mechanisms, and
successive dilutions were made from the stock solution and
subjected to in vitro assays as already described49 to evaluate
the antioxidant activity of the samples. The sample concen-
trations providing 50% of antioxidant activity or 0.5 of absor-
bance (EC50) were calculated from the graphs of antioxidant
activity percentages (DPPH, β-carotene/linoleate and TBARS
assays) or absorbance at 690 nm (reducing power assay)
against sample concentrations. Commercially available Trolox
was used as a reference standard.
2.5.2. Folin–Ciocalteu assay. One mL of the extractive solu-
tion was mixed with 5 mL Folin–Ciocalteu reagent (previously
diluted 1 : 10, v/v with water) and sodium carbonate (75 g L−1,
4 mL). The tubes were vortexed for 15 s and allowed to
incubate for 30 min at 40 °C, followed by the absorbance
measurement at 765 nm (Analytikjena spectrophotometer;
Jena, Germany). The commercially available gallic acid was
used as a standard. The reduction of the Folin–Ciocalteu
reagent was expressed in mg of gallic acid equivalents (GAE)
per g of extract.
2.5.3. Reducing power or ferricyanide/Prussian blue assay.
This assay was performed using a microplate reader and the
capacity of the sample to convert Fe3+ into Fe2+ was evaluated.
Briefly, the extract solutions with different concentrations
(0.5 mL) were mixed with sodium phosphate buffer (200 mmol
L−1, pH 6.6, 0.5 mL) and potassium ferricyanide (1% w/v,
0.5 mL). The mixture was incubated at 50 °C for 20 min, and
trichloroacetic acid (10% w/v, 0.5 mL) was further added.
Furthermore, the mixture (0.8 mL) was pipetted in a 48-well
plate. The procedure was repeated with deionized water as a
blank (0.8 mL) and ferric chloride (0.1% w/v, 0.16 mL), and
afterwards the absorbance was measured at 690 nm using an
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ELX800 microplate reader (Bio-Tek Instruments, Inc.;
Winooski, VT, USA).
2.5.4. DPPH radical-scavenging activity assay. Briefly, 30 μL
of the extract and 270 μL of methanol containing DPPH rad-
icals (6 × 10−5 mol L−1) were pipetted and mixed in a 96 well-
plate. The reaction mixture was incubated in the dark for
30 min at room temperature, and the absorption was
measured at 515 nm using a microplate reader.42 The DPPH
radical scavenging activity (RSA) was calculated as a percentage
of DPPH discolouration using the following equation: % RSA =
[(ADPPH − AS)/ADPPH] × 100, where AS is the absorbance of the
sample and ADPPH is the absorbance of the DPPH solution.
2.5.5. Inhibition of β-carotene bleaching or β-carotene/
linoleate assay. The neutralization of linoleate free radicals
evaluated through the β-carotene/linoleate assay avoids
β-carotene bleaching, and was used to measure the antioxidant
capacity of the sample. Briefly, a solution of β-carotene was pre-
pared by dissolving 2 mg of β-carotene in 10 mL chloroform.
Furthermore, 2 mL of this solution were pipetted into a round-
bottom flask. The chloroform was removed at 40 °C under
vacuum using a rotary evaporator and 40 mg linoleic acid, 400 mg
Tween 80 emulsifier, and 100 mL distilled water were added to
the flask under vigorous shaking. Aliquots (4.8 mL) of this emul-
sion were transferred into test tubes containing 0.2 mL of a range
of concentrations of the extract. The tubes were shaken and incu-
bated in a water bath at 50 °C. The zero time absorbance was
measured at 470 nm (AnalytikJena, Jena, Germany), immediately
after the emulsion was added to each tube.5
2.5.6. Thiobarbituric acid reactive substance (TBARS)
assay. Porcine (Sus scrofa) brains were obtained from officially
slaughtered animals, dissected, and further homogenized with
a Polytron homogenizer in ice cold Tris-HCl buffer (20 mM,
pH 7.4) to yield a 1 : 2 w/v brain tissue homogenate.42 The
porcine brain homogenate was centrifuged for 10 min at
3000g, and afterwards an 100 µL aliquot of the supernatant
was incubated for 1 h at 37 °C with 200 µL samples of a range
of concentrations of the extract in the presence of FeSO4
(10 mM; 100 µL) and ascorbic acid (0.1 mM; 100 µL). After the
incubation time, the reaction was stopped by adding 500 µL
trichloroacetic acid (28% w/v), followed by 380 µL thio-
barbituric acid (TBA, 2%, w/v). The mixture was then incu-
bated again for 20 min at 80 °C. Afterwards, the samples were
centrifuged at 3000g for 10 min to remove the precipitated pro-
teins, and the absorbance of the malondialdehyde (MDA)–TBA
complex in the supernatant was measured at 532 nm. Using
the following equation the inhibition ratio (%) was calculated:
Inhibition ratio (%) = [(A − B)/A] × 100%, where A and B were
the absorbance of the control and the sample solution,
respectively.50
2.6. Evaluation of the antimicrobial activity
2.6.1. Antibacterial activity. The following Gram-negative
bacteria were used: Escherichia coli (ATCC 35210), Pseudomonas
aeruginosa (ATCC 27853), Salmonella typhimurium (ATCC
13311), Listeria monocytogenes (NCTC 7973), Enterococcus
faecalis (human isolate) and the following Gram-positive
bacteria: Bacillus cereus (clinical isolate), Micrococcus flavus
(ATCC 10240) and Staphylococcus aureus (ATCC 6538). Bioassay
is carried out by the microdilution method.
The bacterial cell suspension was adjusted with sterile
saline to a concentration of approximately 1.0 × 105 in a final
volume of 100 μL per well. The extract was dissolved in 5%
DMSO (1 mg mL−1) and added into a Tryptic Soy broth (TSB)
medium (100 μL) with bacterial inoculum (1.0 × 104 CFU per
well) to achieve the desired concentration. The microplates
were incubated using a rotary shaker (160 rpm) for 24 h at 37°
C. The following day, 30 μL of 0.2 mg mL−1 solution of INT
(p-iodonitrotetrazolium violet) was added, and the plates were
returned to the incubator for at least one-half hour to ensure
an adequate colour reaction.51,52 The inhibition of growth was
indicated by a clear solution or a definite decrease in color
reaction. The lowest concentrations without visible growth
(using the binocular microscope) were defined as concen-
trations that completely inhibited bacterial growth (MICs). The
MBCs were determined by serial sub-cultivation of 2 μL of the
extract into microtitre plates containing 100 μL of broth per
well and further incubation for 24 h. The lowest concentration
with no visible growth was defined as the MBC, indicating
99.5% killing of the original inoculum. The optical density of
each well was measured at a wavelength of 655 nm by micro-
plate manager 4.0 (Bio-Rad Laboratories) and compared with a
blank and the positive control. The antibiotics streptomycin
and ampicillin were used as positive controls (1 mg mL−1 in
sterile physiological saline). Three independent experiments
were performed in triplicate.
2.6.2. Antiquorum and antibiofilm activity
Bacterial strains, growth media and culture conditions.
P. aeruginosa PA01 (ATCC 27853) used in this study is from the
collection of the Mycoteca, Institute for Biological Research
“Sinisa Stankovic”, Belgrade, Serbia. Bacteria were routinely
grown in Luria–Bertani (LB) medium (1% w/v NaCl, 1% w/v
tryptone, 0.5% w/v yeast extract) with shaking (220 rpm) and
cultured at 37 °C.
Biofilm formation. The effect of different concentrations of
extract (ranging from 0.5 to 0.125 of MIC, MIC was 0.2 mg mL−1)
on biofilm forming ability was tested on polystyrene flat-
bottomed microtitre 96 well plates as described in ref. 53 and
54 with some modifications. Briefly, 100 µL of overnight
culture of P. aeruginosa (inoculum size was 1 × 108 CFU mL−1)
was added to each well of the plates in the presence of 100 µL
subinhibitory concentrations (subMIC) of extract (0.5, 0.25
and 0.125 MIC) or 100 mL medium (control). After incubation
for 24 h at 37 °C, each well was washed twice with sterile PBS
(pH 7.4), dried, and stained for 10 min with 0.1% crystal violet
in order to determine the biofilm mass. After drying, 200 µL of
95% ethanol (v/v) was added to solubilize the dye that had
stained the biofilm cells. The excess stain was washed off with
dH2O. After 10 min, the content of the wells was homogenized
and the absorbance at λ = 625 nm was read on a Sunrise™
Tecan ELISA reader (Mannedorf, Switzerland). The experiment
was done in triplicate and repeated two times and values were
presented as mean values ± SE.
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Inhibition of biofilm formation of P. aeruginosa. P. aeruginosa
was cultured overnight at 37 °C in LB medium and adjusted to
a concentration of 1.0 × 108 CFU mL−1 for final inoculum.
Filter paper discs (Whatman; 4 mm in diameter) were impreg-
nated with a solution of P. squamosus extract (0.125, 0.25,
0.5 mg per disc), streptomycin and ampicillin (0.125, 0.25,
0.5 mg per disc). Discs were dried at room temperature (3 h,
protected from light), and aseptically placed onto the plates
prior inoculated with P. aeruginosa (1 × 108 CFU mL−1). Petri
dishes were placed for incubation in a thermostat at 37 °C for
24 h. After incubation, whether inhibition or antiquorum
zones were obtained was recorded. Minimal inhibitory concen-
trations were determined as a diameter of the growth clear
inhibition zones around the discs (no growth at all), while
antiquorum, i.e., antibiofilm zones were determined as trans-
parent zones around the discs (growth with different character-
istics) behind the margin of the inhibition zone.55 The experi-
ment was done in triplicate and repeated two times and values
were presented as mean values ± SE.
Inhibition of twitching and flagellar motility of P. aeruginosa.
After growth in the presence or absence of P. squamosus extract
(subMIC 0.15 mg mL−1), streptomycin and ampicillin (subMIC
0.15 mg mL−1), the cells of P. aeruginosa PA01 were washed
twice with sterile PBS and re-suspended in PBS at 1 × 108 CFU
mL−1 (OD of 0.1 at 660 nm). Briefly, the cells were stabbed into
a nutrient agar plate with a sterile toothpick and incubated
overnight at 37 °C. The plates were then removed from the
incubator and incubated at room temperature for two more
days. Colony edges and the zone of motility were measured
with a light microscope.55,56 Fifty microlitres of P. squamosus
extract was mixed into 10 mL of molten MH (Mueller–Hinton)
agar medium and poured immediately over the surface of a
solidified LB agar plate as an overlay. The plate was point
inoculated with an overnight culture of PAO1 once the overlaid
agar had solidified and incubated at 37 °C for 3 days. The
extent of swimming was determined by measuring the area of
the colony. The experiment was done in triplicate and repeated
two times. The colony diameters were measured three times in
different directions and the values were presented as mean
values ± SE.
Inhibition of synthesis of P. aeruginosa PA01 pyocyanin.
Overnight culture of P. aeruginosa PA01 was diluted to
OD600 nm 0.2. Then, P. squamosus extract (250 μL), 0.125 MIC
(0.025 mg mL−1), 0.25 MIC (0.05 mg mL−1) and 0.5 MIC
(0.10 mg mL−1) were added to P. aeruginosa (4.75 mL) and
incubated at 37 °C for 24 h. The treated culture was extracted
with chloroform (3 mL), followed by mixing the chloroform
layer with 0.2 M HCl (1 mL). Absorbance of the extracted
organic layer was measured at 520 nm using a Shimadzu
UV1601 spectrophotometer (Kyoto, Japan).57 The experiment
was done in triplicate and repeated two times. The values for
OD were presented as mean values ± SE.
2.6.3. Antifungal activity. For the antifungal bioassays, fol-
lowing fungi were used: Aspergillus fumigatus (plant isolate),
Aspergillus niger (ATCC 6275), Aspergillus versicolor (ATCC 11730),
Aspergillus ochraceus (ATCC 12066), Penicillium funiculosum
(ATCC 36839), Penicillium ochrochloron (ATCC 9112),
Penicillium verrucosum (food isolate) and Trichoderma viride
(IAM 5061). Bioassay is carried out by the microdilution
method. The fungal spores were washed from the surface of
agar plates with sterile 0.85% saline containing 0.1% Tween 80
(v/v). The spore suspension was adjusted with sterile saline to
a concentration of approximately 1.0 × 105 in a final volume of
100 μl per well. Minimum inhibitory concentration (MIC)
determinations were performed by a serial dilution technique
using 96-well microtiter plates. The extract was dissolved in
5% DMSO (1 mg mL−1) and added in Sabouraud broth
medium (SDA) (100 μL) with bacterial inoculum (1.0 × 104 CFU
per well) to achieve the desired concentration. The microplates
were incubated using a rotary shaker (160 rpm) for 24 h at 28°
C. The lowest concentrations without visible growth (using the
binocular microscope) were defined as MICs. The fungicidal
concentrations (MFCs) were determined by serial subcultiva-
tion of a 2 μl of sample into microtiter plates containing 100 μl
of broth per well and further incubation for 72 h at 28 °C. The
lowest concentration with no visible growth was defined as
MFC indicating 99.5% killing of the original inoculums.58
Each experiment was repeated in triplicate. Commercial fungi-
cides, ketoconazole and bifonazole were used as positive con-
trols (0.10–3.50 mg mL−1).
3. Results and discussion
3.1. Chemical composition of Polyporus squamosus
Research on the chemical composition of P. squamosus was
conducted to target different classes of bioactive compounds.
To the best of our knowledge, this is the first study referring to
the chemical composition of P. squamosus fruiting bodies orig-
inating from Romania. Results concerning the nutritional
value and individual sugars are presented in Table 1.
Carbohydrates were the most abundant class of macronutri-
ents with 74.22 g per 100 g dw, followed by proteins (18.7 g per
100 g dw), ash (5.7 g per 100 g dw), and fat (1.46 g per 100 g
dw), having an energetic value of 384.7 kcal per 100 g dw. The
fruiting body of P. squamosus represents a very good low-fat
medicinal food which can be used on a regular basis. The
Table 1 Nutritional value and free sugar composition of Polyporus
squamosus (mean ± SD)
Polyporus squamosus
Fat (g per 100 g dw) 1.46 ± 0.02
Protein (g per 100 g dw) 18.7 ± 0.1
Ash (g per 100 g dw) 5.7 ± 0.1
Carbohydrates (g per 100 g dw) 74.22 ± 0.01
Energetic value (kcal per 100 g dw) 384.7 ± 0.4
Sugars (g per 100 g dw)
Fructose 0.730 ± 0.004
Mannitol 1.05 ± 0.02
Trehalose 6.81 ± 0.03
Sum 8.59 ± 0.06
dw – dry weight.
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nutritional composition of P. squamosus from the present
study was similar to one of the specimens collected from
Northeast Portugal (Bragança) and Northern Serbia, where
carbohydrates and proteins were also described as being the
most abundant macronutrients.24 Additionally, our results are
in line with the findings of Akata et al. who reported a similar
trend in macronutrient composition: carbohydrates 65.24%,
proteins 13.32%, fat 3.98%, and ash 7.14%.36
Regarding sugar composition, trehalose was the most abun-
dant compound (6.81 g per 100 g dw), while fructose was
found in the smallest amount (0.730 g per 100 g dw). In a pre-
vious study conducted by our team on P. squamosus fruiting
bodies originating from Portugal and Serbia, trehalose was
also found as being the most abundant sugar, while rham-
nose, not detected in the herein sample, was found in the
smallest amount, for both samples.24 Among organic acids, it
was possible to identify oxalic, quinic, malic and fumaric acids
(Table 2). Malic acid was detected in the highest amount
(2.21 g per 100 g dw), whilst fumaric and oxalic acids were
detected in much lower amounts (0.0003 g per 100 g dw, and
0.076 g per 100 g dw). In a similar manner to our results,
malic acid was described as being the most abundant organic
acid in samples of P. squamosus originating from Portugal and
Serbia, while quinic acid was not detected.24 An important fact
is that the presence of these compounds in foods not only
influences their flavor, but also the stability, acceptability and
shelf-life.59 Moreover, organic acids present in natural matrices
are involved in the reduction of oxidative stress.60
Phenolic compounds which contribute directly to anti-
oxidative protection and play an important role in stabilizing
lipid peroxidation were also determined in the studied
sample,11 being identified as p-hydroxybenzoic acid and
p-coumaric acid (Table 2). Similarly, Fernandes et al.24 described
p-hydroxybenzoic acid as the main phenolic acid in samples of
P. squamosus of different origins, while cinnamic acid, a pheno-
lic-related compound, was also found in small amounts.
Lipophilic compounds, including fatty acids and toco-
pherols, were also characterized (Table 3), and twenty-three
fatty acids were identified, both saturated and unsaturated.
The fatty acids determined in high percentages were linoleic
(C18:2n6), oleic (C18:1n9) and palmitic (C16:0) acids.
Moreover, polyunsaturated fatty acids, which are known to
possess several health beneficial effects, were found to be pre-
dominant in P. squamosus (57.37%), followed by monounsatu-
rated fatty acids (24.96%), and saturated fatty acids (17.68%).
In the previous report of Fernandes et al.24 a similar fatty acid
pattern was described in P. squamosus from different origins,
being C18:2n6, C18:1n9 and C16:0 the main fatty acids.
Tocopherols are known to be powerful natural antioxidants,
and are present in natural sources usually as a mixture of four
isomers (namely α-, β-, γ-, and δ-tocopherol).10,49 α-, β-, γ- and
δ-Tocopherols were found in the analyzed sample, and
β-tocopherol was determined in the highest amount (114.7 µg
per 100 g dw). Interestingly, β-tocopherol was also described as
the dominant tocopherol in P. squamosus originating from
Portugal, while γ-tocopherol was predominate for the Serbian
originating sample. According to Fernandes et al.24 these
differences could be ascribed to natural variability inherent to
samples grown under different environmental conditions.
3.2. Antioxidant activity of Polyporus squamosus extract
The maintenance of equilibrium between free radical pro-
duction and antioxidant defenses is an essential condition for
normal organism functioning, and an eventual imbalance is
Table 2 Organic and phenolic acids of Polyporus squamosus (mean ±
SD)
Organic acids (g per 100 g dw)
Oxalic acid 0.076 ± 0.001
Quinic acid 1.40 ± 0.02
Malic acid 2.21 ± 0.01
Fumaric acid 0.0003 ± 0.0001
Total organic acids 3.69 ± 0.04
Phenolic acids (mg per 100 g dw)
p-Hydroxybenzoic acid 2.03 ± 0.05
p-Coumaric acid 0.272 ± 0.002
Total phenolic compounds 2.34 ± 2.26
Related compounds (mg per 100 g dw)
Cinnamic acid 0.037 ± 0.001
dw – dry weight.
Table 3 Fatty acid and tocopherol composition of Polyporus squamo-
sus (mean ± SD)
Polyporus squamosus
C6:0 0.033 ± 0.001
C10:0 0.025 ± 0.001
C12:0 0.049 ± 0.002
C14:0 0.246 ± 0.001
C14:1 0.011 ± 0.001
C15:0 1.09 ± 0.01
C16:0 13.40 ± 0.07
C16:1 0.83 ± 0.01
C17:0 0.123 ± 0.002
C18:0 1.20 ± 0.02
C18:1n9 22.27 ± 0.01
C18:2n6 56.55 ± 0.04
C18:3n3 0.441 ± 0.005
C20:0 0.132 ± 0.001
C20:1 0.151 ± 0.001
C20:2 0.161 ± 0.003
C20:3n3 + C21:0 0.16 ± 0.01
C20:5n3 0.059 ± 0.006
C22:0 1.04 ± 0.03
C22:1n9 0.36 ± 0.02
C23:0 0.10 ± 0.01
C24:0 0.235 ± 0.004
C24:1 1.34 ± 0.02
Total SFA (% of total FA) 17.68 ± 0.04
Total MUFA (% of total FA) 24.96 ± 0.01
Total PUFA (% of total FA) 57.37 ± 0.03
Tocopherols (µg per 100 g dw)
α-Tocopherol 1.54 ± 0.05
β-Tocopherol 114.7 ± 0.8
γ-Tocopherol 5.3 ± 0.5
δ-Tocopherol 3.7 ± 0.4
Total tocopherols 125.2 ± 0.6
SFA – saturated fatty acids; MUFA – monounsaturated fatty acids; PUFA
– polyunsaturated fatty acids.
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reflected through the accumulation of damaged cell structures
(cell membranes, proteins). Compounds from wild mush-
rooms have been described as excellent natural antioxidants.11
In the present study, the antioxidant activity of P. squamosus
was evaluated through five assays involving different mecha-
nisms: reducing power, radical scavenging activity and lipid
peroxidation inhibition (Table 4). For the radical scavenging
(DPPH scavenging activity), lipid peroxidation inhibition
(TBARS, β-carotene/linoleate) and reducing power activities
(ferricyanide/Prussian blue assay) the results are presented in
EC50 values, indicating that higher values correspond to lower
reducing potential (ferricyanide/Prussian blue) or antioxidant
potential, whereas for the Folin–Ciocalteu assay (which
measures the reducing power of the extract in relation to the
molybdenum ion present in the Folin–Ciocalteu reagent),
higher values indicate higher reducing power.61 As seen in
Table 4, the highest measured antioxidant effect of
P. squamosus extract was found in the TBARS inhibition assay
(EC50 = 0.22 mg mL
−1), followed by β-carotene/linoleate (EC50 =
1.41 mg mL−1), ferricyanide/Prussian blue reducing activity
(EC50 = 2.35 mg mL
−1), and DPPH scavenging activity (EC50 =
8.2 mg mL−1). A similar trend was observed in the study of
Fernandes et al.,24 in which the highest antioxidant effect of
P. squamosus extracts from different origins was also measured
for the TBARS inhibition assay. Nevertheless, other authors
have previously reported higher DPPH scavenging and redu-
cing power activities in P. squamosus from Turkey.36,38
3.3. Antimicrobial activity of Polyporus squamosus extract
The results of the antimicrobial activity indicate that
P. squamosus extract possesses a good antibacterial activity on
E. cloacae and B. cereus, while the extract was not active on the
tested fungi. Additionally, according to the previous findings
of Fernandes et al., S. aureus was the most sensitive strain to
P. squamosus extract with a MIC value of 0.20 mg mL−1 and
a MBC value of only 0.39 mg mL−1, which are much more
lower as the results presented herein for the same strain.24
Moreover, the bacteriostatic concentration of P. squamosus
extract for P. aeruginosa was determined by the microdilution
method to be 0.6–20.4 mg mL−1 and the bactericidal concen-
tration is from 1.2–40.8 mg mL−1 (Table 5).
The effect of P. squamosus extract on biofilm formation of
P. aeruginosa was tested with 10.0 mg (0.5 MIC), 5.0 mg (0.25
MIC) and 2.5 mg mL−1 (0.125 MIC). Under the concentration
of 0.5 MIC of tested extract only 36.0% of P. aeruginosa
biofilm was inhibited, ampicillin inhibited 30.9% and strepto-
mycin 50.7% of biofilm formation. P. squamosus extract at 0.25
MIC inhibited 35.5% of biofilm formation, and ampicillin and
streptomycin 43.5% and 29%, respectively. The lowest concen-
tration of extract, 0.125 MIC inhibited biofilm formation of
4%, ampicillin of 7.8% and streptomycin 11.4% (Table 6).
The extract of P. squamosus was tested for the twitching
motility effect on the P. aeruginosa colony and producing of
pili. The untreated colonies of P. aeruginosa were flat with a
Table 4 Antioxidant activity of the Polyporus squamosus extract (mean ± SD)
Reducing power Radical scavenging activity Lipid peroxidation inhibition
Folin–Ciocalteu
(mg GAE per g extract)
Ferricyanide/Prussian
blue (EC50; mg mL
−1)
DPPH scavenging




−1) TBARS (EC50; mg mL
−1)
17.9 ± 0.1 2.35 ± 0.02 8.2 ± 0.1 1.41 ± 0.01 0.22 ± 0.01
Concerning the Folin–Ciocalteu assay, higher values mean higher reducing power; for the other assays, the results are presented in EC50 values,
which means that higher values correspond to lower reducing power or antioxidant potential. EC50: extract concentration corresponding to 50%
of antioxidant activity or 0.5 of absorbance for the ferricyanide/Prussian blue assay. Trolox EC50 values: 0.041 mg mL
−1 (reducing power),
0.042 mg mL−1 (DPPH scavenging activity), 0.018 mg mL−1 (β-carotene bleaching inhibition) and 0.023 mg mL−1 (TBARS inhibition).















P. squamosus MIC 10.2 ± 0.02 20.4 ± 0.09 20.4 ± 0.05 0.61 ± 0.02 20.4 ± 0.02 1.2 ± 0.02 20.4 ± 0.05 20.4 ± 0.08
MBC 20.4 ± 0.02 40.8 ± 0.06 40.8 ± 0.06 1.2 ± 0.03 40.8 ± 0.20 2.4 ± 0.03 40.8 ± 0.60 40.8 ± 0.80
Ampicillin MIC 0.13 ± 0.03 0.13 ± 0.03 0.18 ± 0.03 0.17 ± 0.02 0.20 ± 0.03 0.17 ± 0.02 0.10 ± 0.01 0.40 ± 0.03
MBC 0.15 ± 0.05 0.20 ± 0.03 0.27 ± 0.02 0.20 ± 0.06 0.33 ± 0.05 0.20 ± 0.06 0.20 ± 0.06 0.67 ± 0.08
Streptomycin MIC 0.07 ± 0.06 0.17 ± 0.01 0.13 ± 0.03 0.03 ± 0.00 0.22 ± 0.06 0.03 ± 0.00 0.13 ± 0.02 0.13 ± 0.03
MBC 0.17 ± 0.03 0.27 ± 0.00 0.20 ± 0.05 0.07 ± 0.00 0.40 ± 0.08 0.07 ± 0.00 0.30 ± 0.03 0.23 ± 0.02
MIC – Minimum inhibitory concentrations; MBC – minimum bactericidal concentrations.
Table 6 Percentage of inhibition of biofilm formation after treatment
with subinhibitory concentrations of sample (mean ± SD)
1/2 MIC 1/4 MIC 1/8 MIC
P. squamosus 36.0 ± 1.50 35.5 ± 1.80 4.0 ± 0.08
Ampicillin 30.9 ± 2.40 43.5 ± 2.10 7.8 ± 0.06
Streptomycin 50.7 ± 3.80 29.0 ± 0.90 11.4 ± 0.09
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rough appearance displaying irregular colony edges (Fig. 1A)
and a hazy zone surrounding the colony. It can be noted that
extract applied in 0.25 MIC on P. aeruginosa colony influenced
the reduction of twitching and bacteria produced almost
round, smooth, irregular colony edges, and the pili were
reduced both in size and in numbers, (Fig. 1B). The reduction
of pili and changes in their shape and size were more obvious
at a concentration of extract in 0.5 MIC, (Fig. 1C).
Streptomycin reduced the pili completely (Fig. 1D).
The concentrations of 0.5 MIC P. squamosus extract were
tested for antipyocyanin production by P. aeruginosa. At the
tested concentrations of the extract the green pigment content
was not decreased. Ampicillin (19%) and streptomycin (21%)
also possessed very low potential in reduction of pyocyanin
production (Table 7).
4. Conclusions
An in-depth chemical analysis of several classes of compounds
revealed fruiting bodies of P. squamosus from Romania as a
rich source of bioactive molecules with potent in vitro activi-
ties. According to the obtained results, P. squamosus represents
a source of polyunsaturated fatty acids and β-tocopherol.
Moreover, the biological properties of P. squamosus indicate
that it might be further explored as a medicinal mushroom in
the composition of different pharmaceuticals as well as a
dietary supplement. Nonetheless, further studies are needed
to elucidate the different mechanisms of action involved as
well as the specific compounds responsible for the tested bio-
logical activities.
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